CEBPB and NR3C1

  • Number of citations of the paper that reports this interaction (PMID 9817600)
  • 14
  • Data Source:
  • BioGRID (two hybrid, pull down)
  • HPRD (in vivo, in vitro)

CEBPB

NR3C1

Gene Name CCAAT/enhancer binding protein (C/EBP), beta nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
Image
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
  • Inflammatory bowel disease ( 23128233)
Protein-Protein Interactions 54 interactors: AR ATF2 ATF4 CAMK2A CCL3 CEBPA CEBPD CEBPG CREB1 CREBBP DDIT3 EGFR EGR1 ELK1 EP300 ESR1 FOXO1 HMGA1 HMGB1 HNRNPK HOMER3 HSF1 KAT2A KAT2B MAPK1 MAPK3 MED23 MYB MYC NCOR2 NFKB1 NOLC1 NR3C1 PTGES2 RARB RB1 RELA RPS6KA1 RPS6KA5 RUNX1 RUNX2 SMAD3 SMAD4 SMARCA4 SMARCB1 SMARCC1 SP1 SPI1 SPIB SRF STAT5A STAT6 TAF9 TRIM28 135 interactors: ADA AR ARPC5 BAG1 CALM1 CALR CEBPA CEBPB CENPB CHD9 COPS6 CREB1 CREBBP DAP3 DAXX DCAF6 DDX54 ECD ETS1 ETS2 FKBP4 FTH1 FYN GNB1 GNB2 GNB2L1 GRIP1 HDAC6 HMGB1 HMGB2 HMOX2 HNRNPA1 HNRNPU HSP90AA1 HSPA1A HSPD1 IDE IFNGR2 JUN KAT5 KDM5A KPNA2 LCK LRIF1 MAFF MAPK1 MAPK15 MAPK8 MDM2 MED1 MED14 MED25 MSX2 NCL NCOA1 NCOA2 NCOA3 NCOA4 NCOA6 NCOR1 NCOR2 NEDD4L NFKB1 NFKB2 NR0B1 NR1H3 NR2E3 NR2F2 NR2F6 NR3C2 NR4A1 NRIP1 ONECUT1 OSGEP PBX1 PELP1 PIAS2 PML POLR1D POU1F1 POU2F1 POU2F2 PPARGC1A PRKACA PRKDC PRPF6 PSMC3IP PTGES3 PTMS RAD54L2 RAD9A RAF1 RAN RARA RBM14 RELA RNF14 RXRB SFN SLC25A4 SMAD3 SMARCA2 SMARCA4 SMARCB1 SMARCC1 SMARCD1 SMARCE1 SRA1 SRC STAT3 STAT5A STAT5B SUMO1 SUMO4 SVIL SYT1 TADA2A TBP TDG TGFB1I1 TMF1 TP53 TRIM24 TRIM28 TSG101 TXN UBB UBE2I UBE2L3 YWHAH ZBTB16 ZBTB20 ZBTB3 ZBTB9 ZNF496
Entrez ID 1051 2908
HPRD ID 01801 00679
Ensembl ID ENSG00000172216 ENSG00000113580
Uniprot IDs P17676 B7Z7I2 E5KQF5 E5KQF6 F1D8N4 P04150
PDB IDs 1GTW 1GU4 1GU5 1H88 1H89 1H8A 1HJB 1IO4 2E42 2E43 1M2Z 1NHZ 1P93 3BQD 3CLD 3E7C 3H52 3K22 3K23 4HN5 4HN6
Enriched GO Terms of Interacting Partners?
Tagcloud ?
activates  anticancer  atf4  attenuated  autophagy  chip  ddit4  depletion  effectively  elusive  exo  genomic  greatly  largely  mitochondria  mtorc1  nude  pad  pan  perturbation  potentials  remain  resolution  responsive  sesn2  triple  unveiled  xenograft  yw3 
2xglucocorticoid  2xgre  agonism  agonists  beas  bronchial  budesonide  cdkn1c  ciclesonide  combat  dexamethasone  dusp1  fluticasone  formoterol  furoate  glucocorticoid  glucocorticoids  gre  gsk9027  gw870086x  ikk2  phosphoinositide  propionate  reporter  rgs2  ru24858  suboptimal  tsc22d3  viii 
Tagcloud (Difference) ?
activates  anticancer  atf4  attenuated  autophagy  chip  ddit4  depletion  effectively  elusive  exo  genomic  greatly  largely  mitochondria  mtorc1  nude  pad  pan  perturbation  potentials  remain  resolution  responsive  sesn2  triple  unveiled  xenograft  yw3 
2xglucocorticoid  2xgre  agonism  agonists  beas  bronchial  budesonide  cdkn1c  ciclesonide  combat  dexamethasone  dusp1  fluticasone  formoterol  furoate  glucocorticoid  glucocorticoids  gre  gsk9027  gw870086x  ikk2  phosphoinositide  propionate  reporter  rgs2  ru24858  suboptimal  tsc22d3  viii 
Tagcloud (Intersection) ?